Lin Cai
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
SSGJ-608 in moderate-to-severe plaque psoriasis: a multicenter, randomized, open-label, phase 3 study.
Journal: Frontiers in immunology
Published: February 13, 2026
Real-Time Sampling of Rat Femoral Arteriovenous Adventitial Interstitial Fluid by Placement of a Microdialysis Probe.
Journal: Journal of visualized experiments : JoVE
Published: January 19, 2026
HS-20137 for Chinese Moderate-to-Severe Psoriasis: A Randomized, Double-Blinded, Phase 2 Study.
Journal: Dermatology and therapy
Published: January 14, 2026
Rapid Onset of Action and Quality-of-Life Improvements in Chinese Patients with Plaque Psoriasis Treated with Calcipotriol plus Betamethasone Dipropionate Aerosol Foam in a Randomized Phase 3 Trial.
Journal: Dermatology and therapy
Published: January 14, 2026
Juvenile-onset Fabry disease presenting with recurrent fever and arthralgia.
Journal: QJM : monthly journal of the Association of Physicians
Published: November 26, 2025
Bimekizumab efficacy and safety in Chinese patients with psoriasis in the BE SHINING Phase 3 study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 31, 2025
Correction: Investigation of the Efficacy and Safety of Xeligekimab (GR1501) in Patients with Moderate-to-Severe Plaque Psoriasis: A Multicenter, Randomized, Double-Blind Phase II Clinical trial.
Journal: Dermatology and therapy
Published: July 24, 2025
Investigation of the Efficacy and Safety of Xeligekimab (GR1501) in Patients with Moderate-to-Severe Plaque Psoriasis: A Multicenter, Randomized, Double-Blind Phase II Clinical trial.
Journal: Dermatology and therapy
Published: April 22, 2025
Superior efficacy and comparable safety of calcipotriol plus betamethasone dipropionate foam vs. ointment in Chinese patients with plaque psoriasis: A randomized phase 3 trial.
Journal: Chinese medical journal
Published: March 21, 2025
A real-world study of ixekizumab use patterns, switching and efficacy in patients with plaque psoriasis.
Journal: Archives of dermatological research
Published: January 11, 2025
Psoriasis burden trends and future projections in China: global burden of disease study 2021.
Journal: Archives of dermatological research
Published: November 23, 2024
Last Updated: 09/26/2026